Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
about
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials.The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis.A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis.Treating moderate to severe psoriasis - best use of biologics.Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre.Anti-adalimumab and anti-infliximab antibodies developed in psoriasis vulgaris patients reduced the efficacy of biologics: report of two cases.Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients.Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting.Psoriasis treatment with adalimumab in clinical practice: long-term experience in a center for biological therapy in the Czech Republic.
P2860
Q36521206-0B0DD3FC-06F8-45D1-B7F3-08AA715FA956Q37766229-1C9806E5-7640-4D2D-92E9-99FFD4CC4B48Q38053455-4A1F25BD-FA51-4AB3-9215-5D5269202318Q38084325-D4015684-4B92-4627-9FA3-78B55E220D9BQ38174153-D5BBCBFA-E76C-46FB-B933-00AF9FFDBCBBQ44920372-00387CF1-6961-4B86-8553-705CEED9DF2BQ45911203-FEDF3444-419B-4308-A61F-78CFAC4BFDC4Q46007579-9E60CE3A-5624-43DE-96F5-D647CFBF5047Q46735206-5D3F236F-3C26-44C5-8906-58287F99B4CCQ48298598-1F233FE3-CFE2-4F56-A38D-9202219C743A
P2860
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@en
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@nl
type
label
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@en
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@nl
prefLabel
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@en
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@nl
P2093
P1476
Adalimumab treatment for severe recalcitrant chronic plaque psoriasis.
@en
P2093
P304
P356
10.1111/J.1365-2230.2008.03161.X
P577
2009-04-27T00:00:00Z